Biocon Biologics

(14 search results)

Boost For India’s Generic Pharma Majors
Biocon shares rise 2% on deal with Sandoz
Biocon shares surge 3% on integration of Viatris’ biosimilar business in 31 European countries
Biocon shares drop 6% after USFDA inspection of Malaysian unit
Healthcare sector M&A deals surge 85% in H1FY23: Grant Thornton
Biocon Biologics completes acquisition of Viatris biosimilars biz for $3.3 bn
Biocon says 'all product approvals are legitimate' in bribery case for insulin approval
Bold bet! Biocon Biologics buys Viatris biosimilars assets for $3.33 billion
Biocon wins US patent battle against Sanofi on insulin biosimilar
Walgreens to sell Biocon's insulin Semglee in the U.S.